The devices, distributed between Dec. 12, 2011, and Feb. 29, 2024, are under a Class I recall — the most serious FDA-issued recall.
The anesthesia workstation is intended for use in anesthetizing adults, children and neonates and can be used for automatic and manual ventilation, pressure-supported spontaneous breathing and spontaneous breathing, according to an April 25 FDA alert.
If the Perseus shuts down suddenly, patients may not receive enough ventilation or enough oxygen, causing serious injury or death.
Draeger has reported four incidents related to this issue, but no injuries or deaths.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.